SG Americas Securities’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-425,096
| Closed | -$680K | – | 2612 |
|
|
2025
Q1 | $680K | Buy |
+425,096
| New | +$680K | ﹤0.01% | 1359 |
|
|
2024
Q4 | – | Sell |
-24,941
| Closed | -$142K | – | 2736 |
|
|
2024
Q3 | $142K | Buy |
+24,941
| New | +$142K | ﹤0.01% | 2474 |
|
|
2024
Q2 | – | Sell |
-22,368
| Closed | -$183K | – | 2471 |
|
|
2024
Q1 | $183K | Buy |
+22,368
| New | +$183K | ﹤0.01% | 1812 |
|
|
2023
Q4 | – | Sell |
-11,921
| Closed | -$22K | – | 2780 |
|
|
2023
Q3 | $22K | Sell |
11,921
-889
| -7% | -$1.64K | ﹤0.01% | 2712 |
|
|
2023
Q2 | $35K | Sell |
12,810
-15,203
| -54% | -$41.5K | ﹤0.01% | 1866 |
|
|
2023
Q1 | $88K | Sell |
28,013
-13,532
| -33% | -$42.5K | ﹤0.01% | 2692 |
|
|
2022
Q4 | $245K | Buy |
41,545
+2,087
| +5% | +$12.3K | ﹤0.01% | 1858 |
|
|
2022
Q3 | $346K | Buy |
39,458
+7,785
| +25% | +$68.3K | ﹤0.01% | 1666 |
|
|
2022
Q2 | $239K | Buy |
+31,673
| New | +$239K | ﹤0.01% | 2312 |
|
|
2022
Q1 | – | Sell |
-7,149
| Closed | -$230K | – | 2628 |
|
|
2021
Q4 | $230K | Sell |
7,149
-4,592
| -39% | -$148K | ﹤0.01% | 2346 |
|
|
2021
Q3 | $525K | Buy |
11,741
+7,451
| +174% | +$333K | ﹤0.01% | 2258 |
|
|
2021
Q2 | $162K | Buy |
4,290
+318
| +8% | +$12K | ﹤0.01% | 2197 |
|
|
2021
Q1 | $147K | Buy |
+3,972
| New | +$147K | ﹤0.01% | 2608 |
|